Neurodevelopmental status and quality of life of survivors from a randomized , placebo-controlled trial of fluconazole prophylaxis were evaluated at 8 to 10 years of life using the Vineland Adaptive Behavior Scales-II ( VABS-II ) and the Child Health Questionnaire Parent-Completed Form 28 ( CHQ-PF28 ) , respectively .
